WEBULL
News
RHHBF
420.00
-0.94%
-4.00
Roche Vs. Eli Lilly: Nvidia Deals, Obesity Battles Stoke Rivalry (I'd Buy Both)
Seeking Alpha · 6h ago
FTC monitoring how Big Pharma reacts to upcoming patent cliffs, official says
Seeking Alpha · 12h ago
EXCLUSIVE-Altai Capital presses OraSure to sell and give it board seats, letter says
Reuters · 1d ago
NVIDIA CORP: ROCHE SCALES NVIDIA AI FACTORIES GLOBALLY TO ACCELERATE DRUG DISCOVERY, DIAGNOSTIC SOLUTIONS & MANUFACTURING BREAKTHROUGHS
Reuters · 2d ago
NVIDIA - ROCHE DEPLOYS MORE THAN 3,500 NVIDIA BLACKWELL GPUS GLOBALLY FOR R&D PRODUCTIVITY, NEXT-GENERATION DIAGNOSTICS & MANUFACTURING EFFICIENCIES
Reuters · 2d ago
BRIEF-Roche Launches Nvidia AI Factory To Accelerate The Development Of New Therapeutics And Diagnostics Solutions
Reuters · 2d ago
Roche expands hybrid-cloud AI factory to more than 3,500 NVIDIA Blackwell GPUs
Reuters · 2d ago
Roche ramps up AI computing capacity with Nvidia chip expansion
Reuters · 2d ago
Weekly Report: what happened at RHHBF last week (0309-0313)?
Weekly Report · 2d ago
Roche receives CE approval for Elecsys ApoE4 biomarker test
Seeking Alpha · 2d ago
Roche Wins CE Mark For First Blood-Based IVD Immunoassay Identifying ApoE4 Genetic Variant Linked To Up To 60% Of Diagnosed Alzheimer's Disease Cases
Benzinga · 2d ago
Roche wins CE mark for Elecsys ApoE4 blood test for Alzheimer’s carrier screening
Reuters · 2d ago
ROCHE RECEIVES CE MARK FOR FIRST IVD IMMUNOASSAY BLOOD TEST TO IDENTIFY CARRIERS OF APOE4, A GENETIC VARIANT PRESENT IN UP TO 60% OF PATIENTS DIAGNOSED WITH ALZHEIMER'S DISEASE
Reuters · 2d ago
CORRECTED-What to Watch in the Week Ahead and on Monday, March 16
Reuters · 5d ago
Roche Falters In A Key Breast Cancer Readout
Seeking Alpha · 03/11 15:44
Regeneron: Fairly Valued Now After A Stellar Upswing
Seeking Alpha · 03/11 13:47
Spruce Biosciences names Dale Hooks chief commercial officer
Reuters · 03/09 11:00
Weekly Report: what happened at RHHBF last week (0302-0306)?
Weekly Report · 03/09 10:35
Roche stock falls after breast cancer combo therapy fails in trial
Seeking Alpha · 03/09 10:21
Roche's Phase III persevERA Study Of Giredestrant Plus Palbociclib Misses Primary Endpoint In ER-Positive Advanced Breast Cancer But Shows Numerical Improvement In Progression-Free Survival
Benzinga · 03/09 06:48
More
Webull provides a variety of real-time RHHBF stock news. You can receive the latest news about Roche Hldgs Ag through multiple platforms. This information may help you make smarter investment decisions.
About RHHBF
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.